Nalaganje...
JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B‐Cell Lymphoma Growth by Increasing Apoptosis and Disrupting Cell Proliferation
BACKGROUND: Canine diffuse large B‐cell lymphoma (DLBCL) is a common and aggressive hematologic malignancy. The lack of conventional therapies with sustainable efficacy warrants further investigation of novel therapeutics. The Janus kinase (JAK) and signal transducer and activator of transcription (...
Shranjeno v:
| izdano v: | J Vet Intern Med |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697192/ https://ncbi.nlm.nih.gov/pubmed/28960447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.14837 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|